OA
Operose Advisors’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $829K | Hold |
4,465
| – | – | 0.23% | 56 |
|
2025
Q1 | $936K | Sell |
4,465
-1,106
| -20% | -$232K | 0.31% | 45 |
|
2024
Q4 | $990K | Buy |
5,571
+1,204
| +28% | +$214K | 0.34% | 40 |
|
2024
Q3 | $862K | Buy |
4,367
+34
| +0.8% | +$6.71K | 0.28% | 50 |
|
2024
Q2 | $743K | Sell |
4,333
-250
| -5% | -$42.9K | 0.26% | 51 |
|
2024
Q1 | $835K | Buy |
4,583
+2,630
| +135% | +$479K | 0.28% | 49 |
|
2023
Q4 | $303K | Sell |
1,953
-467
| -19% | -$72.4K | 0.12% | 85 |
|
2023
Q3 | $361K | Buy |
2,420
+834
| +53% | +$124K | 0.14% | 69 |
|
2023
Q2 | $214K | Hold |
1,586
| – | – | 0.1% | 80 |
|
2023
Q1 | $253K | Sell |
1,586
-549
| -26% | -$87.5K | 0.13% | 57 |
|
2022
Q4 | $345K | Buy |
2,135
+549
| +35% | +$88.7K | 0.18% | 43 |
|
2022
Q3 | $213K | Buy |
1,586
+136
| +9% | +$18.3K | 0.14% | 56 |
|
2022
Q2 | $222K | Hold |
1,450
| – | – | 0.16% | 51 |
|
2022
Q1 | $235K | Hold |
1,450
| – | – | 0.16% | 56 |
|
2021
Q4 | $196K | Buy |
+1,450
| New | +$196K | 0.16% | 58 |
|